Top movers in Wednesday's session

ADAMIS PHARMACEUTICALS CORP (ADMP)       0.1985   -0.03 (-11.82%)

After market: 0.2051 +0.01 (+3.32%)


News Image
Top movers in Wednesday's session11 days ago - Chartmill

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

Top gainers

TickerChangeComment
MOHO38.03%ECMOHO LTD's (NASDAQ:MOHO) stock price is advancing with 38.03% to a price of $0.16. In the last month the share price dropped with 23.83%.
CRKN23.07%CROWN ELECTROKINETICS CORP's (NASDAQ:CRKN) shares rose 23.07% to $0.46. In the last month the stock lost 42.08%.
CRH.W17.14%COHN ROBBINS HOLDINGS -CW25 (NYSE:CRH.W) rose 17.14% to $0.41 during Wednesday's after hours session. Shareholders saw the stock price going 28.57% lower in the past month.
FREY16.52%FREYR BATTERY SA's (NYSE:FREY) stock price is advancing with 16.52% to a price of $15.31. In the last month the stock gained 29.97%.
AVCTW15.89%PENSARE ACQUISITION CORP-CW's (NASDAQ:AVCTW) shares rose 15.89% to $0.05. In the last month the stock gained 22.6%.
ANPC15.33%ANPAC BIO-MEDICAL SCIENC-ADR's (NASDAQ:ANPC) stock price is advancing with 15.33% to a price of $0.17. In the last month the share price dropped with 57.88%.
AMEH13.17%APOLLO MEDICAL HOLDINGS INC's (NASDAQ:AMEH) shares rose 13.17% to $44.3. In the last year the share price dropped with 59.07%.
SFIX13.03%STITCH FIX INC-CLASS A's (NASDAQ:SFIX) stock price increased by 13.03% to $5.33. In the last 3 months the share price dropped with 23.62%.
CREX12.1%CREATIVE REALITIES INC's (NASDAQ:CREX) shares rose 12.1% to $0.69. Shareholders saw the stock price going 27.54% lower is the past 6 months.
ALLG11.46%ALLEGO NV's (NYSE:ALLG) shares rose 11.46% to $6.03 during Wednesday's session. The stock is trading 71.1% lower than 6 months ago.

Our top gainers screener will show you the full list.

Losers

TickerChangeComment
CBIO-74.63%CATALYST BIOSCIENCES INC's (NASDAQ:CBIO) shares fell 74.63% to $0.49 during Wednesday's session. The stock is trading 28.48% higher than 3 months ago.
ADMP-38.89%ADAMIS PHARMACEUTICALS CORP's (NASDAQ:ADMP) shares fell 38.89% to $0.22. Shareholders saw the stock price going 20.92% lower in the past 3 months.
SESN-35.82%SESEN BIO INC's (NASDAQ:SESN) shares fell 35.82% to $0.43. A press release (SESN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Sesen Bio, Inc. Is Fair to Shareholders) was released earlier today.
PIXY-33.09%SHIFTPIXY INC's (NASDAQ:PIXY) shares fell 33.09% to $14.41 during Wednesday's session. The stock is trading 29.85% lower than 3 months ago.
OPP--32.0%River North Dble Line Strtgc Opp Fd [Opp/I/R]'s (NYSE:OPP-) shares fell 32.0% to $0.0. In the last month the stock lost 50.98%.
SOBR-26.64%SOBR SAFE INC's (NASDAQ:SOBR) stock price decreased by 26.64% to $2.22. In the last month the share price increased with 168.0%.
BCAN-24.5%BYND CANNASOFT ENTERPRISES's (NASDAQ:BCAN) shares fell 24.5% to $4.5 during Wednesday's session. In the last month the stock gained 25.04%.
PBTS-22.27%POWERBRIDGE TECHNOLOGIES CO's (NASDAQ:PBTS) shares fell 22.27% to $1.71 during Wednesday's session. In the last month the stock gained 59.46%.
VTAQ-20.13%VENTOUX CCM ACQUISITION CORP's (NASDAQ:VTAQ) stock price decreased by 20.13% to $4.88. The stock is trading 40.22% lower than a month ago.
MEDS-19.85%TRXADE HEALTH INC's (NASDAQ:MEDS) shares fell 19.85% to $1.09. Shareholders saw the stock price going 40.35% lower is the past 6 months.

Our top losers screener will show you the full list.

Back

ADMP Links

ADMP News

News Image10 days ago - ChartmillTop movers in Thursday's pre-market session

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.

News Image11 days ago - Market News VideoWednesday Sector Laggards: Drugs, AirlinesNews Image11 days ago - Adamis Pharmaceuticals CorporationAdamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects

Interim data from the Phase 2/3 clinical trial of Tempol did not demonstrate statistical significance of its primary endpoint of clinical resolution of...

News Image20 days ago - Adamis Pharmaceuticals CorporationAdamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects

The clinical trial of Tempol has reached the initial planned enrollment of 248 subjects Independent Data Monitoring Board to review interim data from...

News Image2 months ago - Adamis Pharmaceuticals CorporationAdamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders

Meeting adjourned only with respect to reverse stock split proposal until September 8, 2022...

News Image2 months ago - Adamis Pharmaceuticals CorporationAdamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 1:30 p.m. PT / 4:30 p.m. ...

News Image2 months ago - Adamis Pharmaceuticals CorporationAdamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and...

Follow us for more